Africa’s Only CAP-Accredited Central Lab
From complexity to clarity – cost-effective, high-impact clinical trials in Sub-Saharan Africa, powered by the integration of MLM Medical Labs and Cytespace Africa Laboratories
Global Trials. Accelerated in Africa
Reach diverse, treatment-naïve patient populations with faster start-up times and lower recruitment costs.
With geopolitical changes limiting access to traditional recruitment hubs, sponsors are turning to Africa—an equally rich, underutilized alternative offering competitive per-patient costs, large treatment-naïve cohorts, and diverse genomic representation.
■ Strategic reach: Trial-ready infrastructure in South Africa with service coverage across 17 African countries.
■ Scientific depth: PhD-led teams with Africa-specific trial expertise.
■ Proven compliance: Africa’s first and only fully CAP-accredited central lab.
The Cytespace + MLM Difference:
Unlike outsourced partnerships, MLM owns and operates its African facility outright—ensuring stability, accountability, and the same scientific rigor that defines our global network.
Infectious Disease Testing Built for This Moment
Accelerate infectious disease trials with advanced diagnostics and proven logistics.
■ Two Biosafety Level 3 TB laboratories for complex tuberculosis research.
■ GeneXpert®, QuantiFERON®, and advanced molecular assays.
■ Optimized cold-chain logistics to maintain sample integrity across challenging environments.
The MLM + Cytespace Difference: MLM is the only global central lab with wholly owned, CAP-accredited operations in Africa, seamlessly connected to our labs in Europe and North America and partners in Asia.
The MLM + Cytespace Difference
MLM is the only global central lab with wholly owned, CAP-accredited operations in Africa, seamlessly connected to our labs in Europe and North America and partners in Asia.
Data You Can Trust. Compliance You Can Count On.
Running trials in Africa can bring unique challenges—regulatory friction, evolving country-specific guidelines, and sample handling delays. With MLM, sponsors avoid those costly pitfalls.
■ 99% on-time sample turnaround for 48-hour TATs.
■ Expert navigation of complex African regulatory frameworks.
■ Consolidated reporting through MLM’s proprietary global platforms.
■ On-the-ground logistics teams with deep local networks.
The MLM + Cytespace Advantage
Many sponsors struggle to merge African trial data into global datasets. MLM solves this with proven reporting solutions that ensure visibility, consistency, and compliance across every region.
Scale Confidently Across Continents
Move from preclinical to Phase IV with one global partner.
■ Hundreds of active clinical trials, including global Phase 3 and multi-country programs.
■ Broad therapeutic expertise: oncology, infectious diseases, neurodegeneration, NCDs, and more.
■ In-house kit building, biomarker analysis, histology, and logistics support.
The MLM + Cytespace Difference
MLM is not a CRO dabbling in lab services—it’s a global laboratory powerhouse with CRO-level agility, wholly owned facilities in Africa, and proven Phase 3 trial execution worldwide.
The Big Idea
The Cytespace acquisition isn’t just more geography — it’s more capability, more trust, and more value for your next trial.
Now, Africa’s fastest-growing clinical trial market is fully connected to MLM’s global network — delivering cost-effective recruitment, treatment-naïve populations, and rapid start-up.
Connect With MLM Medical Labs Today
Expedite your new therapies for patients worldwide using quality clinical safety testing from MLM Medical Labs. Request a proposal or contact us for more information today.
